Table I Index
Table of Contents
|
Table I - 10 Clark Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 393 | 361.8 | 197 | 429.9 | 196 | 315.0 |
| Oral cavity and pharynx | 11 | 10.8** | 7 | 16.0** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 81 | 70.4 | 37 | 79.8 | 44 | 62.0 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 42 | 36.0 | 18 | 38.3** | 24 | 32.7 |
| Rectum and rectosigmoid | 15 | 13.2** | 11 | 24.4** | * | # |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 6 | 5.2** | * | # | 5 | 6.9** |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 94 | 89.5 | 54 | 118.2 | 40 | 68.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 9 | 8.5** | 9 | 19.7** | * | # |
| Lung and bronchus | 83 | 79.2 | 44 | 96.0 | 39 | 67.1 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 12 | 11.5** | 9 | 19.8** | * | # |
| Melanoma of the skin | 12 | 11.5** | 9 | 19.8** | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 47 | 42.3 | * | # | 47 | 75.9 |
| Female genital system | 24 | 21.9 | -- | -- | 24 | 39.9 |
| Cervix uteri | 8 | 7.0** | -- | -- | 8 | 13.3** |
| Corpus uteri | 9 | 8.3** | -- | -- | 9 | 14.8** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 6 | 5.5** | -- | -- | 6 | 9.9** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 40 | 38.1 | 40 | 86.4 | -- | -- |
| Prostate gland | 39 | 37.4 | 39 | 85.0 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 33 | 30.4 | 26 | 57.4 | 7 | 11.7** |
| Urinary bladder | 16 | 13.8** | 14 | 30.9** | * | # |
| Kidney and renal pelvis | 15 | 14.5** | 11 | 24.0** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 6 | 5.5** | * | # | 5 | 7.7** |
| Brain | 5 | 4.1** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 16 | 14.5** | 8 | 16.7** | 8 | 13.8** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 15 | 13.0** | 8 | 16.7** | 7 | 10.9** |
| Multiple myeloma | 6 | 5.8** | * | # | * | # |
| Leukemia | 12 | 10.6** | 6 | 13.1** | 6 | 9.2** |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | 5 | 4.6** | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 7 | 6.4** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||